Drug Type Recombinant polypeptide |
Synonyms NN 9223, NN-9223, NN9223 |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 1 | United States | 01 Oct 2011 |
Phase 1 | 31 | (Cohort 1a: Lira-depot 2.25 mg) | nuzzrwnqvo = wjdoqugoze bgdqrwwgui (phbjzjimcj, bcqhvhsxto - tpsualszwi) View more | - | 04 Sep 2013 | ||
(Cohort 2a: Lira-depot 6.75 mg) | nuzzrwnqvo = hhhdqgljao bgdqrwwgui (phbjzjimcj, asrzsjvlma - nhyiocclpd) View more |